Prateek Jain
@prateekim7
Followers
38
Following
84
Media
1
Statuses
5
Internal medicine resident - Sinai hospital of Baltimore/ Research Fellow - Mayo Clinic, AZ / 1% better every day — the Mamba way
Baltimore, MD
Joined July 2024
Excited to share our new study. Real-World Outcomes of Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma. Deeply grateful to my mentors for their guidance @Parminder1699 @IrbazRiaz
https://t.co/Nr25WUSvrs
clinical-genitourinary-cancer.com
MicroabstractEvidence on the real-world efficacy of enfortumab vedotin–pembrolizumab in advanced urothelial carcinoma remains limited. In this retrospective study of 183 patients, the combination...
0
1
4
Come say hi to us and get to know what makes our program so special! #MedTwitter #match2026 #IMresidency
0
5
17
Honored to present my poster on the prognostic utility of ctDNA in MIBC and mUC at the @GUconference Always grateful to my mentors @Parminder1699 and @IrbazRiaz for their guidance and to my program @SinaiBmoreIMRes for their support in making this opportunity possible
1
3
14
Lines of Therapy for Locally Advanced/Metastatic Urothelial Carcinoma: The New Paradigm | JCO Oncology Practice https://t.co/3lPXX8IRn9 Sharing our recent review appreciate reviewers for feedback. Great work by Fellow - @sesayo @prateekim7
@neerajaiims @PGrivasMDPhD @shilpaonc
ascopubs.org
Urothelial carcinoma (UC) is the most common malignancy of the urinary tract, with urothelial bladder cancer accounting for approximately 90% of cases. Metastatic UC (mUC) is a particularly aggress...
2
14
33
Congratulations to this year's #WorldGU25 poster winners! We are excited to spotlight our 19 winners at the Poster Session & Welcome Reception at the 2-day CE-accredited conference in Nashville, TN, Aug 21-23. Join us and receive up to 11.75 CE credits. https://t.co/R9dYRQvvXE
0
10
23